DK340489A - Fremstilling af svaekkede rna virale stammer og vacciner omfattende disse - Google Patents

Fremstilling af svaekkede rna virale stammer og vacciner omfattende disse Download PDF

Info

Publication number
DK340489A
DK340489A DK340489A DK340489A DK340489A DK 340489 A DK340489 A DK 340489A DK 340489 A DK340489 A DK 340489A DK 340489 A DK340489 A DK 340489A DK 340489 A DK340489 A DK 340489A
Authority
DK
Denmark
Prior art keywords
rna viral
weaked
stems
preparation
vaccines including
Prior art date
Application number
DK340489A
Other languages
Danish (da)
English (en)
Other versions
DK340489D0 (da
Inventor
Carolyn Louise Weeks-Levy
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK340489D0 publication Critical patent/DK340489D0/da
Publication of DK340489A publication Critical patent/DK340489A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
DK340489A 1989-06-08 1989-07-10 Fremstilling af svaekkede rna virale stammer og vacciner omfattende disse DK340489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36361189A 1989-06-08 1989-06-08

Publications (2)

Publication Number Publication Date
DK340489D0 DK340489D0 (da) 1989-07-10
DK340489A true DK340489A (da) 1990-12-09

Family

ID=23430924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK340489A DK340489A (da) 1989-06-08 1989-07-10 Fremstilling af svaekkede rna virale stammer og vacciner omfattende disse

Country Status (10)

Country Link
EP (1) EP0401421B1 (es)
JP (1) JPH0310683A (es)
AT (1) ATE132527T1 (es)
AU (1) AU630099B2 (es)
DE (1) DE68925356T2 (es)
DK (1) DK340489A (es)
ES (1) ES2084587T3 (es)
FI (1) FI893346A (es)
GR (1) GR3018670T3 (es)
IL (1) IL90743A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004003045A1 (de) 2004-01-20 2005-08-18 Man Roland Druckmaschinen Ag Formatanpassung für Produktionsdaten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800100D0 (en) * 1988-01-05 1988-02-10 Almond J W Attenuated viruses
ATE121779T1 (de) * 1988-01-11 1995-05-15 American Cyanamid Co Nichtzurückschlagende rns-viren.
GB8901094D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses

Also Published As

Publication number Publication date
DK340489D0 (da) 1989-07-10
EP0401421A2 (en) 1990-12-12
DE68925356D1 (de) 1996-02-15
AU3713489A (en) 1990-12-13
AU630099B2 (en) 1992-10-22
FI893346A0 (fi) 1989-07-10
EP0401421B1 (en) 1996-01-03
GR3018670T3 (en) 1996-04-30
JPH0310683A (ja) 1991-01-18
IL90743A0 (en) 1990-01-18
EP0401421A3 (en) 1991-01-30
DE68925356T2 (de) 1996-09-05
IL90743A (en) 1996-01-19
FI893346A (fi) 1990-12-09
ATE132527T1 (de) 1996-01-15
ES2084587T3 (es) 1996-05-16

Similar Documents

Publication Publication Date Title
DE68929467D1 (de) HIV-2 Varianten
LU91152I2 (fr) étanique, d'anatoxine coquelucheuse, d'hémagglutinCombinaison d'anatoxine diphtérique, d'anatoxine tine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
PT84155A (en) Method of modifying plant viruses or their effects
DK0404625T3 (da) Oligonukleotidsekvenser til amplifikation af genomer af retrovirus af HIV-2 og SIV-typen samt deres anvendelser til in vitro-diagnose af infektioner forårsaget af disse virus
NO903757L (no) Kitin.kitosan-oligomer med 2,5-anhydromannitol endegruppeeller 2,5-anhydromannose endegruppe og fremgangsmaate til fremstilling derav.
DK8789A (da) Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse
NO900943D0 (no) Kopolymerer, fremgangsmaate for deres fremstilling og anvendelse.
NO903169L (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
DE69738512D1 (de) Epstein-barr virus type b ctl epitopen
DK340489A (da) Fremstilling af svaekkede rna virale stammer og vacciner omfattende disse
DK0385909T3 (da) Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner
DE69014100T2 (de) Cdns des orsv-virus gens.
DK295388D0 (da) 1-oe(phenothiazin-10-yl)-alkylaa-alfa-phenyl-4-piperidinmethanoler, deres fremstilling og anvendelse.
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
NO885058L (no) 6-oxoprostaglandin-e-derivater, fremgangsmaater for fremstilling av disse og deres farmasoeytiske anvendelse.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment